Lucid Lane Inc. is a US-based startup that focuses on empowering individuals dealing with substance use and pain to lead healthier lives. The company provides a comprehensive telehealth solution for pain, mental health, and substance use. Their mission involves collaborating with hospitals, surgeons, and doctors to embed themselves in clinical pathways to treat patients dealing with acute and chronic pain management alongside co-occurring mental health and substance use issues such as opioid, benzo, and alcohol dependence.
The Lucid Lane solution includes licensed therapists who offer individualized mind-body therapy, medication tapering planning, and medication-assisted treatment in over 35 states. Additionally, patients have access to virtual video-based support groups moderated by counselors, 24/7 In-the-Moment chat, and daily messaging support. The company continuously monitors patients for various aspects of well-being and functioning and provides alerts in real-time to offer proactive help, personalizing treatment plans based on evolving patient needs. The startup also has clinical outcomes metrics demonstrating the efficacy of their program.
The company has attracted significant investment, with a Series A investment of $16.00M on 05 August 2021 from notable investors including Accel, Battery Ventures, AME Cloud Ventures, Morado Ventures, and Dhiren Bhatia.
In summary, Lucid Lane Inc. has positioned itself at the intersection of technology and healthcare with a focus on addressing critical issues related to pain management and substance use, drawing substantial support from prominent investors.No recent news or press coverage available for Lucid Lane Inc..